BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15450817)

  • 21. Remodeling of rat ventral prostate after castration involves heparanase-1.
    Augusto TM; Felisbino SL; Carvalho HF
    Cell Tissue Res; 2008 May; 332(2):307-15. PubMed ID: 18278514
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research advancement on heparanase in tumor metastasis].
    Li ZH; Yang SM
    Ai Zheng; 2005 Sep; 24(9):1156-60. PubMed ID: 16159446
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanisms of heparanase inhibitors in cancer therapy.
    Heyman B; Yang Y
    Exp Hematol; 2016 Nov; 44(11):1002-1012. PubMed ID: 27576132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A liquid chromatography-mass spectrometry-based approach to characterize the substrate specificity of mammalian heparanase.
    Mao Y; Huang Y; Buczek-Thomas JA; Ethen CM; Nugent MA; Wu ZL; Zaia J
    J Biol Chem; 2014 Dec; 289(49):34141-51. PubMed ID: 25336655
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis of simple heparanase substrates.
    Pearson AG; Kiefel MJ; Ferro V; von Itzstein M
    Org Biomol Chem; 2011 Jun; 9(12):4614-25. PubMed ID: 21505696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparanase induces vascular endothelial growth factor expression: correlation with p38 phosphorylation levels and Src activation.
    Zetser A; Bashenko Y; Edovitsky E; Levy-Adam F; Vlodavsky I; Ilan N
    Cancer Res; 2006 Feb; 66(3):1455-63. PubMed ID: 16452201
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparanase uptake is mediated by cell membrane heparan sulfate proteoglycans.
    Gingis-Velitski S; Zetser A; Kaplan V; Ben-Zaken O; Cohen E; Levy-Adam F; Bashenko Y; Flugelman MY; Vlodavsky I; Ilan N
    J Biol Chem; 2004 Oct; 279(42):44084-92. PubMed ID: 15292202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a colorimetric assay for heparanase activity suitable for kinetic analysis and inhibitor screening.
    Hammond E; Li CP; Ferro V
    Anal Biochem; 2010 Jan; 396(1):112-6. PubMed ID: 19748475
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting.
    Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I
    J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Synthetic Antimicrobial Peptide 19-2.5 Interacts with Heparanase and Heparan Sulfate in Murine and Human Sepsis.
    Martin L; De Santis R; Koczera P; Simons N; Haase H; Heinbockel L; Brandenburg K; Marx G; Schuerholz T
    PLoS One; 2015; 10(11):e0143583. PubMed ID: 26600070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparanase coagulation and cancer progression.
    Nadir Y; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-performance liquid chromatographic/mass spectrometric studies on the susceptibility of heparin species to cleavage by heparanase.
    Bisio A; Mantegazza A; Urso E; Naggi A; Torri G; Viskov C; Casu B
    Semin Thromb Hemost; 2007 Jul; 33(5):488-95. PubMed ID: 17629845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Requirement of the conserved, hydrophobic C-terminus region for the activation of heparanase.
    Lai NS; Simizu S; Morisaki D; Muroi M; Osada H
    Exp Cell Res; 2008 Sep; 314(15):2834-45. PubMed ID: 18662687
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparan sulfate inhibitors and their therapeutic implications in inflammatory illnesses.
    Ferro V
    Expert Opin Ther Targets; 2013 Aug; 17(8):965-75. PubMed ID: 23789629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Function of heparanase in prostate tumorigenesis: potential for therapy.
    Lerner I; Baraz L; Pikarsky E; Meirovitz A; Edovitsky E; Peretz T; Vlodavsky I; Elkin M
    Clin Cancer Res; 2008 Feb; 14(3):668-76. PubMed ID: 18212251
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.
    Wu ZL; Huang X; Ethen CM; Tatge T; Pasek M; Zaia J
    Glycobiology; 2017 Jun; 27(6):518-524. PubMed ID: 28025251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Spatiotemporal expression of heparanase during human and rodent ovarian folliculogenesis.
    Haimov-Kochman R; Prus D; Zcharia E; Goldman-Wohl DS; Natanson-Yaron S; Greenfield C; Anteby EY; Reich R; Orly J; Tsafriri A; Hurwitz A; Vlodavsky I; Yagel S
    Biol Reprod; 2005 Jul; 73(1):20-8. PubMed ID: 15728796
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Development of Assays for Heparanase Enzymatic Activity: Towards a Gold Standard.
    Chhabra M; Ferro V
    Molecules; 2018 Nov; 23(11):. PubMed ID: 30441818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Testing of potential glycan-based heparanase inhibitors in a fluorescence activity assay using either bacterial heparinase II or human heparanase.
    Schoenfeld AK; Vierfuß S; Lühn S; Alban S
    J Pharm Biomed Anal; 2014 Jul; 95():130-8. PubMed ID: 24667567
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.